• Dyspnea
  • Chromosome Analysis, Amniotic Fluid
  • Malignant neoplasm, pituitary gland
  • CACNA1A (calcium voltage-gated channel subunit alpha1 A) Gene Mutation Analysis
  • Chlamydia trachomatis NAAT, Urine
  • Phosphorylated tau 217 (pTau 217), Plasma, (Quest AD-Detect®, ALZpath pTau217)
  • Trisomy 21 (Down syndrome)
  • G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
  • Beta-2 Microglobulin, Urine
  • Apolipoprotein A1
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Auria® Biological Breast Cancer Screening Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Auria® Biological Breast Cancer Screening Test
Medical Test

Interpretation
Access to Auria® Biological Breast Cancer Screening Test is restricted.
Loading...